Abstract

Optimal digestion serves many physiological roles including assimilation of nutrients, sustaining the commensal bacterial environment of the gut microbiome, supporting daily bowel movements and elimination of toxins. An individual’s health and quality of life can be sustained and/or lost at the interface of the external world entering the gut as gut-brain, nervous system, and microbial forces all interact to influence gut function and digestion. This review of digestive function and loss thereof focuses on ways to optimize gut health by mimicking the intrinsic homeostasis of the Rest and Digest parasympathetic regulation of secretions and motility and the bidirectional gut-brain cross-talk of the microbial commensals. Supporting mastication, digestive secretions, motility, and the microbiome can significantly restore gastrointestinal homeostasis and its vital role in overall health.

Keywords: Digestion; Assimilation; Dysbiosis; Microbiome; Gut-brain Axis; Natural Therapy

References

1. Guilliams T. “Functional Strategies for the Management of Gastrointestinal Disorders”. Point Institute Wisconsin (2016).
2. Foster JA., et al. “Gut-brain axis: how the microbiome influences anxiety and depression”. Trends in Neuroscience5 (2013): 305-312.
3. Breton J., et al. “Ecotoxicology inside the gut: impact of heavy metals on the mouse microbiome”. BMC Pharmacology and Toxicology 14 (2013): 62.
4. Miro-Blanch J and Yanes O. “Epigenetic Regulation at the Interplay Between Gut Microbiota and Host Metabolism”. Frontier in Genetics (2019).
5. Hullar MA and Fu BC. “Diet, the gut microbiome, and epigenetics”. Cancer Journal3 (2014): 170-175.
6. Paul B., et al. “Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases”. Clinical Epigenetics 7 (2015): 112.
7. Quigley EM. “Microflora modulation of motility”. Journal of Neurogastroenterology and Motility 2 (2011): 140-147.
8. Konturek PC., et al. “Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options”. Journal of Physiology and Pharmacology 6 (2011): 591-599.
9. Bruno G., et al. “Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified”. World Journal of Gastroenterology22 (2019): 2706-2719.
10. Kines K., et al. “Nutritional Interventions for Gastroesophageal Reflux, Irritable Bowel Syndrome, and Hypochlorhydria: A Case Report”. Integratated Medicine (Encinitas) 15.4 (2016): 49-53.
11. , et al. “Dietary behaviors in relation to prevalence of irritable bowel syndrome in adolescent girls”. Journal of Gastroenterology and Hepatology 33.2 (2018): 404-410.
12. Gropper SS and Smith JL. “Advanced Nutrition and Human Metabolism”. 6th ed. Wadsworth: Cengage Learning (2013).
13. Martinez KB., et al. “Western diets, gut dysbiosis, and metabolic diseases: Are they linked?” Gut Microbes2 (2017): 130-142.
14. El-Salhy M., et al. “Dietary fiber in irritable bowel syndrome (Review)”. International Journal of Molecular Medicine 3 (2017): 607-613.
15. Hall John E. “Guyton and Hall Textbook of Medical Physiology”. 13th ed. Guyton Physiology. London, England: W B Saunders (2015).
16. Browning KN and Travagli RA. “Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions”. Comprehensive Physiology4 (2014): 1339-1368.
17. Power ML and Schulkin J. “Anticipatory physiological regulation in feeding biology: cephalic phase responses”. Appetite 2-3 (2008): 194-206.
18. Miquel-Kergoat S., et al. “Effects of chewing on appetite, food intake and gut hormones: A systematic review and meta-analysis”. Physiology Behavior 151 (2015): 88-96.
19. Compare D., et al. “Effects of long-term PPI treatment on producing bowel symptoms and SIBO”. European Journal of Clinical Investigation 4 (2011): 380-386.
20. Lacy BE., et al. “Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?”. Gastroenterology and Hepatology (N Y)11 (2011): 729-739.
21. Chedid V., et al. “Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth”. Global Advances in Health and Medicine 3 (2014): 16-24.
22. Gantzer J. “Eat Your Fats, Skip the Carbs: Here’s Why. A Dietary Fat Metabolic Journey". Acta Scientific Neurology Special Issue 1 (2019): 01-04.
23. Green CL and Lamming DW. “Regulation of metabolic health by essential dietary amino acids”. Mechanisms of Ageing and Development 177 (2019): 186-200.
24. Ward E. “Addressing nutritional gaps with multivitamin and mineral supplements”. Nutrition Journal 13 (2014): 72.
25. Huang D. “Dietary Antioxidants and Health Promotion”. Antioxidants (Basel)1 (2018): 9.
26. Lord RS and Bralley JA. “Laboratory Evaluations for Integrative and Functional Medicine”. 2nd. Duluth, GA: Genova Diagnostics (2012).
27. Lord R. “Paths to Health: Gut Microbes”. Chanhassen, MN: Arrowhead Bioscience (2018).
28. Jazani NH., et al. “Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease”. Diseases 1 (2019): 21.
29. Guerreiro CS., et al. “Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis”. Frontiers in Medicine (Lausanne) 5 (2018): 349.
30. Wallace JL., et al. “Hydrogen sulfide: an agent of stability at the microbiome-mucosa interface”. American Journal of Physiology-Gastrointestinal and Liver Physiology 2 (2018): G143-G149.
31. Blachier F., et al. “Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin”. Current Opinion in Clinical Nutrition and Metabolic Care 1 (2019): 68-75.
32. Barton LL., et al. “Sulfur Cycling and the Intestinal Microbiome”. Digestive Diseases and Sciences 9 (2017): 2241-2257.
33. Tang Y., et al. “Gut Microbiota Dysbiosis Enhances Migraine-Like Pain Via TNFα Upregulation”. Molecular Neurobiology (2019).
34. Lee SY., et al. “Microbiome in the Gut-Skin Axis in Atopic Dermatitis”. Allergy, Asthma and Immunology Research 4 (2018): 354-362.
35. Clapp M., et al. “Gut microbiota's effect on mental health: The gut-brain axis”. Clinical Practice4 (2017): 987.
36. Rogers GB., et al. “From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways”. Molecular Psychiatry 6 (2016): 738-748.
37. Li Y., et al. “The Role of Microbiome in Insomnia, Circadian Disturbance and Depression”. Frontiers in Psychiatry 9 (2018): 669.
38. Du Preez S., et al. “A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis”. Systematic Review1 (2018): 241.
39. Sachdev AH and Pimentel M. “Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance”. Therapeutic Advances in Chronic Disease5 (2013): 223-231.
40. Mohajeri MH., et al. “The role of the microbiome for human health: from basic science to clinical applications”. European Journal of Nutrition 57 (2018): 1-14.
41. Imhann F., et al. “Proton pump inhibitors affect the gut microbiome”. Gut 65 (2016): 740-748.
42. Cater RE. “Helicobacter (aka Campylobacter) pylori as the major causal factor in chronic hypochlorhydria”. Medical Hypotheses4 (1992): 367-374.
43. Waldum HL., et al. “Helicobacter pylori and gastric acid: an intimate and reciprocal relationship”. Therapeutic Advances in Gastroenterology 6 (2016): 836-844.
44. Lin HC. “Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome”. JAMA 292 (2004): 852-858.
45. Esposito I., et al. “Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics”. World Journal of Gastroenterology45 (2007): 6016-6021.
46. Anderson JM and Van Itallie CM. “Physiology and function of the tight junction”. Cold Spring Harbor Perspectives in Biology 2 (2009): a002584.
47. Mu Q., et al. “Leaky Gut As a Danger Signal for Autoimmune Diseases”. Frontiers in Immunology 8 (2017): 598.
48. Fasano A. “Zonulin, regulation of tight junctions, and autoimmune diseases”. Annals of the New York Academy of Sciences 1 (2012): 25-33.
49. Hollon J., et al. “Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity”. Nutrients3 (2015): 1565-1576.
50. Foster JA., et al. “Stress and the gut-brain axis: Regulation by the microbiome”. Neurobiology Stress 7 (2017): 124-136.
51. Kelly JR., et al. “Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders”. Frontiers in Cell Neuroscience 9 (2015): 392.
52. Ianiro G., et al. “Digestive Enzyme Supplementation in Gastrointestinal Diseases”. Current Drug Metabolism 2 (2016): 187-193.
53. Magge S., et al. “Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome”. Gastroenterology and Hepatology (N Y) 11 (2012): 739-745.
54. , et al. “The Intestinal Life Cycle of Bacillus subtilis and Close Relatives”. Journal of Bacteriology 188.7 (2006): 2692-2700.
55. Salvatore S., et al. “A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease”. Aliment Pharmacology Therapy 12 (2000): 1567-1579.
56. Murray MT. “Glycyrrhiza glabra (Licorice)”. Textbook of Natural Medicine (2020): 641-647.e3.
57. Hałasa M., et al. “Oral Supplementation with Bovine Colostrum Decreases Intestinal Permeability and Stool Concentrations of Zonulin in Athletes”. Nutrients4 (2017): 370.

Citation

Citation: Jennifer Gantzer. “Supporting Gut Health by Homeostasis and Intrinsic Mechanisms”. Acta Scientific Neurology 4.11 (2021): 10-17.

Copyright

Copyright: © 2021 Jennifer Gantzer. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.